Effect of vitamin E on the development of atherosclerosis

Toxicology

Volumn 148, Issue 2-3, 2000, Pages 179-185

  Özer, Nesrin Kartal ^a   Azzi, Angelo ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Atherosclerosis; Probucol; Protein kinase C; Vascular smooth muscle cell; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROGENESIS; ATHEROSCLEROSIS; CELL PROLIFERATION; CHOLESTEROL DIET; CONFERENCE PAPER; CONTROLLED STUDY; HEART INFARCTION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ARTERIOSCLEROSIS; CELL DIVISION; CELL LINE; CHOLESTEROL; CHOLESTEROL, DIETARY; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MUSCLE, SMOOTH, VASCULAR; PROBUCOL; PROTEIN KINASE C; RABBITS; VITAMIN E;

EID: 0037558330     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(00)00209-2     Document Type: Conference Paper

References (37)

1. Alexander D.R. et al. A method for measuring protein kinase C activity in permeabilized T lymphocytes by using peptide substrates. Evidence for multiple pathways of kinase activation. Biochem. J. 268:1990;303-308.
2. Azzi A et al. The protein kinase C family. Eur. J. Biochem. 208:1992;547-557.
3. Azzi A. et al. Vitamin E: a sensor and an information transducer of the cell oxidation state. Am. J. Clin. Nutr. 62((Suppl.)):1995;1337S-1346S.
4. Bocan T.M. et al. The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation. Atherosclerosis. 102:1993;9-22.
5. Bornancin F., Parker P.J. Phosphorylation of threonine 638 critically controls the dephosphorylation and inactivation of protein kinase Cα Curr. Biol. 6:1996;1114-1123.
6. Bornfeldt K.E. et al. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J. Clin. Invest. 93:1994;1266-1274.
7. Boscoboinik D. et al. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J. Biol. Chem. 266:1991;6188-6194.
8. Boscoboinik D. et al. Inhibition of protein kinase C activity and vascular smooth muscle cell growth by d-alpha-tocopherol. Biochim. Biophys. Acta. 1224:1994;418-426.
9. Boscoboinik D. et al. Tocopherols and 6-hydroxy-chroman-2-carbonitrile derivatives inhibit vascular smooth muscle cell proliferation by a nonantioxidant mechanism. Arch. Biochem. Biophys. 318:1995;241-246.
10. Carew T.E. et al. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. USA. 84:1987;7725-7729.
11. Castellot J.J. et al. Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells. J. Cell Biol. 109:1989;3147-3155.
12. Chatelain E. et al. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim. Biophys. Acta. 1176:1993;83-89.
13. Clowes A.W., Schwartz S.M. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ. Res. 56:1985;139-145.
14. Dutil E.M. et al. In vivo regulation of protein kinase C by trans-phosphorylation followed by autophosphorylation. J. Biol. Chem. 269:1994;29359-29362.
15. Esterbauer H. et al. Inhibition of LDL oxidation by antioxidants. EXS. 62:1992;145-157.
16. Ferns G.A. et al. Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit. Proc. Natl. Acad. Sci. USA. 89:1992;11312-11316.
17. Gey K.F. The antioxidant hypothesis of cardiovascular disease: epidemiology and mechanisms. Biochem. Soc. Trans. 18:1990;1041-1045.
18. Gey K.F. et al. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am. J. Clin. Nutr. 57:1993;787S-797S.
19. Konneh M.K. et al. Vitamin E inhibits the intimal response to balloon catheter injury in the carotid artery of the cholesterol-fed rat. Atherosclerosis. 113:1995;29-39.
20. Mantha S.V. et al. Antioxidant enzymes in hypercholesterolemia and effects of vitamin E in rabbits. Atherosclerosis. 101:1993;135-144.
21. Matsumoto H., Sasaki Y. Staurosporine, a protein kinase C inhibitor interferes with proliferation of arterial smooth muscle cells. Biochem. Biophys. Res. Commun. 158:1989;105-109.
22. Muller R. et al. Signals and genes in the control of cell-cycle progression. Biochim. Biophys. Acta. 1155:1993;151-179.
23. Newby A.C. et al. Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C. Br. J. Pharmacol. 114:1995;1652-1656.
24. Newton A.C. Protein kinase C: structure, function, and regulation. J. Biol. Chem. 270:1995;28495-28498.
25. Nierenberg D.W., Nann S.L. A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples. Am. J. Clin. Nutr. 56:1992;417-426.
26. Özer N.K. et al. d-alpha-Tocopherol inhibits low density lipoprotein induced proliferation and protein kinase C activity in vascular smooth muscle cells. FEBS Lett. 322:1993;307-310.
27. Özer N.K. et al. New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis. Biochem. Mol. Biol. Int. 35:1995;117-124.
28. Pryor A.W. et al. A rapid screening test to determine the antioxidant potencies of natural and synthetic antioxidants. J. Org. Chem. 58:1993;3521-3532.
29. Raines E.W., Ross R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br. Heart J. 69:1993;S30-S37.
30. Rimm E.B. et al. Vitamin E consumption and the risk of coronary heart disease in men (see comments). New Engl. J. Med. 328:1993;1450-1456.
31. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
32. Sirikci Ö. et al. Dietary cholesterol-induced changes of protein kinase C and the effect of vitamin E in rabbit aortic smooth muscle cells. Atherosclerosis. 126:1996;253-263.
33. Stahelin H.B. et al. Nutritional factors correlating with cardiovascular disease: results of the Basel Study. Bibl. Nutr. Dieta. 49:1992;24-35.
34. Stampfer M.J. et al. Vitamin E consumption and the risk of coronary disease in women (see comments). New Engl. J. Med. 328:1993;1444-1449.
35. Stein Y. et al. Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels. Atherosclerosis. 75:1989;145-155.
36. Steinberg D. Clinical trials of antioxidants in atherosclerosis: are we doing the right thing. Lancet. 346:1995;36-38.
37. Stephens N.G. et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 347:1996;781-786.